BACKGROUND: Single nucleotide polymorphisms (SNPs) of the adenosine deaminase, RNA-specific (ADAR) gene were reported to be associated with human longevity. There are possibilities that ADAR is associated with major risk factors of atherosclerotic cardiovascular diseases (CVD), such as hypertension, diabetes, dyslipidemia, and obesity. OBJECTIVE: To investigate the association between SNPs of the ADAR gene and clinical data associated with major risk factors of atherosclerotic CVD. SUBJECTS: A total of 1504 general population residents (586 males and 918 females) of two towns, Tanno-cho and Sobestu-cho, in Hokkaido, Japan. METHODS: Clinical data associated with risk factors of atherosclerotic CVD were collected from these study subjects. DNA from peripheral blood and written informed consent were obtained. Three single nucleotide polymorphisms of ADARB1 and ADARB2, which were previously reported to be associated with longevity, were genotyped employing the TaqMan PCR method. The associations between SNPs in ADARB1 and ADARB2 and clinical parameters related to risk factors of atherosclerosis were analyzed. RESULTS: On uni- and multivariate analyses, rs2805533 in ADARB2 was significantly associated with the abdominal circumference, body mass index, serum triglyceride level, and serum adiponectin level. The subjects with the AA genotype of rs2805533 had a greater abdominal circumference, higher body mass index, higher triglyceride level, and lower adiponectin level than those with AG and GG genotypes. CONCLUSION: The SNP in ADARB2 related to longevity is associated with metabolic disorders. This finding suggests that genetic factors modulate human longevity via the regulation of metabolic factors such as abdominal obesity and lipid profiles.
BACKGROUND: Single nucleotide polymorphisms (SNPs) of the adenosine deaminase, RNA-specific (ADAR) gene were reported to be associated with human longevity. There are possibilities that ADAR is associated with major risk factors of atherosclerotic cardiovascular diseases (CVD), such as hypertension, diabetes, dyslipidemia, and obesity. OBJECTIVE: To investigate the association between SNPs of the ADAR gene and clinical data associated with major risk factors of atherosclerotic CVD. SUBJECTS: A total of 1504 general population residents (586 males and 918 females) of two towns, Tanno-cho and Sobestu-cho, in Hokkaido, Japan. METHODS: Clinical data associated with risk factors of atherosclerotic CVD were collected from these study subjects. DNA from peripheral blood and written informed consent were obtained. Three single nucleotide polymorphisms of ADARB1 and ADARB2, which were previously reported to be associated with longevity, were genotyped employing the TaqMan PCR method. The associations between SNPs in ADARB1 and ADARB2 and clinical parameters related to risk factors of atherosclerosis were analyzed. RESULTS: On uni- and multivariate analyses, rs2805533 in ADARB2 was significantly associated with the abdominal circumference, body mass index, serum triglyceride level, and serum adiponectin level. The subjects with the AA genotype of rs2805533 had a greater abdominal circumference, higher body mass index, higher triglyceride level, and lower adiponectin level than those with AG and GG genotypes. CONCLUSION: The SNP in ADARB2 related to longevity is associated with metabolic disorders. This finding suggests that genetic factors modulate human longevity via the regulation of metabolic factors such as abdominal obesity and lipid profiles.
Authors: Rodrigo San-Cristobal; Santiago Navas-Carretero; Fermín I Milagro; J Ignacio Riezu-Boj; Elizabeth Guruceaga; Carlos Celis-Morales; Katherine M Livingstone; Lorraine Brennan; Julie A Lovegrove; Hannelore Daniel; Wim H Saris; Iwonna Traczyk; Yannis Manios; Eileen R Gibney; Michael J Gibney; John C Mathers; J Alfredo Martinez Journal: J Physiol Biochem Date: 2017-03-28 Impact factor: 4.158
Authors: Adam Lewis; Lisa Bastarache; Anita Pandit; Daniel B Larach; Jing He; Anik Sinha; Nicholas J Douville; Michael Heung; Michael R Mathis; Jonathan D Mosley; Jonathan P Wanderer; Sachin Kheterpal; Matthew Zawistowski; Chad M Brummett; Edward D Siew; Cassianne Robinson-Cohen; Miklos D Kertai Journal: BMC Nephrol Date: 2022-10-21 Impact factor: 2.585
Authors: Jessié M Gutierres; Fabiano B Carvalho; Maria Rosa C Schetinger; Marília V Rodrigues; Juliano M Vieira; Paula Maldonado; Maria do Carmo S Araújo; Roberta Schmatz; Naiara Stefanello; Jeandre A S Jaques; Marcio Costa; Vera Morsch; Cinthia M Mazzanti; Victor Pimentel; Sonia Terezinha A Lopes; Roselia M Spanevello Journal: J Physiol Biochem Date: 2014-03-13 Impact factor: 4.158
Authors: Silvia von der Heyde; Carolin Fromm-Dornieden; Gabriela Salinas-Riester; Tim Beissbarth; Bernhard G Baumgartner Journal: BMC Genomics Date: 2014-05-18 Impact factor: 3.969